GEMCITABINE INDUCED CARDIOMYOPATHY

Gemcitabine is a pyrimidine antimetabolite that inhibits DNA synthesis and is used commonly as an adjuvant chemotherapy agent for resectable pancreatic cancer as a single agent. Gemcitabine is generally not considered as a cardiotoxic agent and very few case reports exist in literature about